Killer cell immunoglobulin-like receptors (KIR) are highly polymorphic members of the immunoglobulin superfamily, which influence the response of natural killer cells and some T-lymphocyte subsets. Analysis of a cohort of previously human cytomegalovirus (HCMV)-negative patients, who developed primary HCMV infection following HCMV-positive renal transplant (n = 76), revealed an increase in the frequency of KIR genes located on the telomeric region of B haplotypes (Tel B). The presence of Tel B in combination with the KIR ligand HLA-C2 was significantly more frequent in this subgroup. These genetic factors were associated with resistance to HCMV infection in a second cohort (n = 65), where the Tel B genes KIR2DL5, -2DS1, 2DS5 and -3DS1 were all significantly associated with high viral loads. Furthermore, the KIR haplotype Tel A when in combination with the KIR ligand HLA-C1 was significantly protective against the development of severe infection. Our results suggest that KIR are a significant factor in the control of primary HCMV infection, and that determination of KIR gene repertoire may help in detection of renal transplant patients who were most at risk.
INTRODUCTION
Human cytomegalovirus (HCMV) is a common β-herpes virus, which is a significant source of mortality and morbidity in immunocompromised subjects such as transplant recipients or patients with immune deficiency syndromes. HCMV has evolved numerous strategies to elude the immune system and to maintain a chronic infection of the host. 1, 2 This includes impeding human leukocyte antigen (HLA) class I expression and antigen presentation by HCMV-infected cells in order to evade detection by CD8 + T cells. However, these alterations in expression may be detected by innate immune receptors for HLA class I, such as the Killer cell immunoglobulin-like receptors (KIR) molecules, that can mediate natural killer (NK) cell attack.
3 KIR genes display a high level of polymorphism, both in terms of sequence diversity and the presence or absence of particular loci on distinct polymorphic haplotypes. [4] [5] [6] The KIR gene cluster is divided into two distinct haplotype blocks: within the centromeric region, the haplotype termed 'Cen A' carries the inhibitory KIR2DL3, which is replaced by the activating -2DS2 and the inhibitory -2DL2 on the 'Cen B' haplotype. The inhibitory KIR2DL5 gene and the activating -3DS1, -2DS5 and -2DS1 genes are in strong linkage disequilibrium on the telomeric end of the KIR cluster, occurring on haplotypes carrying the telomeric part of the B haplotype, Tel B. 7, 8 They are distinguishable from Tel A haplotypes by the presence of one or more of these activating KIR and the absence of the inhibitory -3DL1. A schematic describing the basic genetic organization of the KIR gene cluster is provided (Supplementary Figure S1 ).
The Ly49 receptors are the functional equivalent of KIR in mice. The lectin-like Ly49H receptor gene, within the NK complex on mouse chromosome 6 has been shown to convey resistance to murine CMV. 9 The Ly49h protein is capable of activating NK cells and mouse strains that express this particular receptor are able to recognize murine CMV-infected targets early in an immune response, preventing infection. 10, 11 To investigate whether the presence or absence of particular KIR influence the development of primary CMV infection in humans, KIR gene repertoire was compared between subgroups of transplant recipients divided on the level of HCMV viral load developed following renal transplantation. All patients studied were HCMV negative before receiving a kidney from an HCMV-positive donor (D + R − ) and have therefore had direct exposure to HCMV.
RESULTS
KIR gene repertoire is associated with susceptibility to HCMV infection We determined the KIR gene repertoire of a cohort of 76 HCMV D + R − renal transplant patients from the Cambridge Transplant Centre. Our analysis revealed an increase in the frequencies of KIR genes occurring on Tel B haplotypes in patients who developed a detectable, active HCMV viral infection (4500 copies per ml) during the initial 6 months post transplant (Figure 1 ). Of these genes, KIR2DS5 showed the greatest increase (P = 0.06, Fisher's exact test, odds ratio (OR) = 2.82, 95% confidence intervals (CIs) = 1.01-7.90). A minor increase in the frequency of Cen B was observed in the 4500 copies per ml subgroup (Supplementary  Table S1 ).
KIR genes in combination with their HLA class I ligands The known ligands of KIR include HLA-Bw4 and HLA-C alleles carrying a C1 or C2 epitope. [12] [13] [14] [15] [16] [17] Analysis of KIR haplotypes and ligand combinations within the Cambridge cohort revealed a statistically significant increase in the frequency of Tel B when in the presence of HLA-C2, within the patient subgroup that developed HCMV 4500 copies per ml (P = 0.01, Fisher's exact test; OR = 4.60, 95% CI = 1.41-15.06) (Figure 1 and Supplementary  Table S1 ). KIR2DS1 is the only KIR encoded within Tel B haplotypes with known specificity for HLA-C2. 18 The increased frequency of KIR2DS1 when in combination with HLA-C2 within the HCMV 4500 copies per ml subgroup was not too dissimilar (P = 0.09; OR = 3.13, 95% CI = 0.85-11.56) than for that of Tel B+HLA-C2 ( Figure 1 and Supplementary Table S1 ).
The assessment of KIR gene repertoires within a comparable cohort The relationship between post-transplant HCMV infection and KIR genotype was assessed further within a D + R − kidney transplant recipient cohort from the Oxford Transplant Centre. This cohort allowed for a more in-depth analysis, as all subjects were more frequently assessed for post-transplant HCMV levels than their Cambridge counterparts. HCMV levels varied considerably between individuals, ranging from those who remained completely virus free over the sampling period (99 days post transplant) to those who developed severe antigenemia levels (⩾100 per 5 × 10 4 peripheral blood mononucleated cell Table S2 ). Tel B when in combination with HLA-C2 was also associated with accelerated development of HCMV infection ( Figure 2 , P = 0.01, log-rank test). Of the individual Tel B genes, KIR2DS1 was significantly associated with accelerated development of HCMV infection when analysed alone (P = 0.05) and when coupled with HLA-C2 (P = 0.01).
KIR gene repertoire is associated with severity of HCMV infection To further assess the relationship between KIR phenotype and post-transplant HCMV levels, the Oxford cohort was divided into three subgroups based on clinically significant peak antigenemia thresholds obtained during the sampling period, based on previously published studies [19] [20] [21] [22] [23] [24] [25] Table S1 ). Conversely, the presence of Tel B in combination with HLA-C2 was associated with an antigenemia of 450 positive cells per 5 × 10 4 (P = 0.05; OR = 4.83; 95% CI = 1.15-20.26), particularly when HLA-C2 was homozygous (P = 0.05; OR = 11.33; 95% CI = 1.05 -122.39; Figure 3a and Supplementary Table S1 ). Identical results were achieved with KIR2DS1 and HLA-C2 combinations (Figure 3b and Supplementary Table S1 ). Homozygosity of HLA-C2 alone was also significantly associated with an antigenemia of 450 cells per 5 × 10 4 (P = 0.03; OR = 8.25; 95% CI = 1.28-53.25; Figure 3a and Supplementary Table S1 ). The impact of Tel B homozygosity could not be assessed due to the low frequency of this genotype.
Analysis of individual KIR gene phenotypes found a significant increase in the frequency of the Tel B genes KIR3DS1, -2DL5, -2DS5 and -2DS1 within the patient subgroup that developed a was the most strongly associated with increased peak antigenemia (P = 0.01, a result replicated by KIR2DS1 in combination with this ligand), while Tel A in combination with HLA-C1 was significantly protective (P = 0.03). Of the individual KIR genes, KIR3DS1, -2DL5, -2DS1 and -2DS5 were all significantly associated with higher peak antigenemia. No other KIR loci or KIR/ligand combination was significantly associated with increased antigenemia levels. Finally, a significant trend was observed between increasing number of activating KIR genes and increasing peak antigenemia levels (P = 0.01, linear regression; Figure 5 ).
DISCUSSION
To best determine the relationship between KIR gene repertoire and primary HCMV infection, only individuals with known exposure to the virus were enrolled in this study. In addition, the choice of patient cohorts enabled us to assess whether Figure 2 . The influence of KIR genotype on the rate of development of HCMV infection during the initial 99 days post transplant in Oxford D + R − renal transplant patients. In each panel, patients were divided into two groups by the presence or absence of a KIR haplotype, gene or a KIR/HLA ligand combination. P-values calculated using log-rank analysis (n/s, not significant).
prophylactic anti-HCMV therapy altered any potential impact of KIR gene repertoire on infection. The KIR genes located within the telomeric region of the KIR B haplotype (specifically -2DS1, -2DL5, -3DS1 and -2DS5 26 ) appeared to influence the development of primary HCMV infection, particularly in terms of severity of infection as determined by antigenemia level. Of the genes studied, KIR2DL5 and -2DS1 consistently gave the strongest associations in the Oxford cohort (Figures 2-4) . These data are all consistent with a Tel B association. KIR2DL5 in itself is not a marker for the Tel B haplotype as there are two -2DL5 loci. However, in Caucasoids, KIR2DL5A, which is more frequent, occurs within the Tel B region, while -2DL5B occurs within the centromeric region of the KIR cluster where it typically encodes a non-expressed variant.
27 KIR2DL5 was strongly associated with increased antigenemia levels (Figures 2-4) . KIR2DL5 is an inhibitory receptor 28 and its ligand is unknown. It is possible that KIR2DL5 binds a ligand induced by HCMV on the surface of infected cells, which inhibits the response of NK cells. This would be comparable to LILRB1-mediated inhibition of NK cells due to the high-affinity interaction of this inhibitory receptor with the HCMV encoded HLA class I homolog UL18. 29 KIR genes are effective when engaged by their respective HLA ligands. Further interrogation of the data involving KIR haplotype and ligand combinations revealed that Tel B in the presence of HLA-C2 was significantly associated with susceptibility to HCMV infection in both cohorts, and with increased peak antigenemia levels in the Oxford cohort. Interestingly, Tel A in the presence of HLA-C1 was significantly protective against the development of severe antigenemia levels, particularly when Tel A was homozygous. This finding is supported by a recent study of various solid organ transplant recipients, where KIR2DL3/KIR2DS2 in the presence of HLA-C1 substantially reduced the hazard of CMV viremia during primary infection. 30 KIR2DS1 is the only Tel B gene with known specificity for HLA-C2. KIR2DS1 in combination with HLA-C2 produced similar results to that of Tel B+HLA-C2, strongly suggesting that this interaction is responsible for the impact of KIR genotype we observed on the development of HCMV infection. The frequencies of activating KIR genes on Tel B haplotypes were increased in the patient subgroups that developed higher HCMV viral loads. These results are in contrast to two previous studies that found the presence of activating KIR reduced the risk of HCMV reactivation following hematopoietic stem cell transplantation. 31, 32 These studies differ fundamentally from ours with respect to the nature of transplantation and the HCMV status of patients before transplant. The positive effects of activating KIR on HCMV reactivation were observed in either non T-cell-depleted hematopoietic stem cell transplantation 31 or T-cell replete hematopoietic stem cell transplantation, 32 and are likely to involve the action of HCMV-specific memory T cells. The renal − renal transplant patients separated by the presence of telomeric 'B' haplotype genes. The haplotypes Tel A and B were also assessed in combination with HLA-C1 and C2, respectively, while KIR3DS1 and -2DS1 were assessed with their putative HLA ligands. Significance was calculated using a two-tailed Mann-Whitney t-test. Bars indicate median values. 44 was excluded from this analysis. KIR2DS4 was also excluded due to the high-frequency soluble form. 45 The median antigenemia values showed a linear increase with the number of activating KIR genes (r 2 = 0.098; P = 0.01). Bars indicate median values. transplant patients studied here were all HCMV negative before transplant and would therefore lack the appropriate T-cell memory during the initial stages of infection, while their primary T-cell responses would have been limited by the effect of the immunosuppressant Cyclosporine A. 33 It is possible that the influence of KIR on post-transplant HCMV levels in the patient cohorts investigated in our study result from the action of NK cells rather than T cells.
Two other studies reported a protective effect of activating KIR on HCMV infection in renal transplant patients. 34, 35 However, only a small minority of the patients studied were HCMV D + R − and the majority of HCMV infections were due to reactivation of the virus. Our study indicates that KIR genes in Tel B were associated with primary infection. Another study reported a significant increase in frequency of KIR3DS1, -2DS5 and -2DL5 in a small cohort of HIV patients who contracted herpes virus immune restoration disease in comparison with patients who remained restoration disease free. 36 At first sight, our findings in this study may appear counterintuitive, where activating KIR genes are linked with accelerated development of HCMV infection. However, a previous study of development of HPV-associated cervical cancer demonstrated that activating KIR genes were linked to susceptibility. 37 Analysis of KIR repertoires at the cellular level and functional NK cell studies will be required to elucidate the precise biological mechanism underlying these findings.
This and previous genetic studies 31, 32, [34] [35] [36] clearly indicate a role for KIR in the development of HCMV infection. Our findings suggest that routine determination of KIR gene repertoire of HCMV-negative renal transplant patients may help to identify those most at risk of infection. Once identified, these patients could receive more intensive management, such as a greater level of prophylaxis or a regular assessment of viral load.
MATERIALS AND METHODS

Patient cohorts
Genomic DNA samples were obtained from two patient cohorts: Cohort 1 consisted of 76 consecutive HCMV D + R − patients who received a kidney transplant between 2000 and 2007 at the Cambridge Transplant Centre. Their pre-transplant serostatus was assessed using CMV latex assays. These patients were selected as they were initially seronegative but subsequently had direct exposure to HCMV from the renal graft. All patients underwent calcineurin inhibitor-based immunosuppression coupled with methylprednisolone and azathioprine, and received either Acyclovir or Valganciclovir anti-HCMV prophylaxis for the initial 3 months post transplant. All patients' HCMV viral loads were assessed by quantitative PCR and were observed for 6 months post transplant. Total nucleic acid extracted from 200 μl of patients' peripheral blood plasma using a MagNA pure extractor (Roche, Basel, Switzerland). Quantitative PCR was performed on a Lightcycler CMV Quantitative assay (Roche) as previously described. 38 A minimum threshold of 4500 viral DNA genome copies per ml was employed, ensuring robust detection of active, albeit low-level HCMV infection. − renal transplant patients identified from an original cohort of~500 patients. 40 Transplants were performed between the years 1992 and 2002 at the Oxford Transplant Centre. All transplant recipients received cyclosporin A (dosage adjusted according to levels), methylprednisolone and azathioprine conventional triple immunosuppressive therapy. They did not undergo anti-HCMV prophylaxis therapy. All were routinely monitored over a 99-day period for HCMV antigenemia levels post transplantation, providing quantitative assessment of HCMV level. Buffy coat cells (5 × 10 4 ) prepared from peripheral blood using a cytospin were assessed for pp65 antigenemia levels by staining with mouse anti-HCMV pp65 antibody (Clonab, Biotest, Dreieich, Germany) and alkaline phosphatase anti-alkaline phosphatase immunochemistry. A maximum threshold of 100 positive cells per 5 × 10 4 was employed. Patients' pre-transplant serostatus was assessed using CMV latex assays (BD Pharmingen, Franklin Lakes, NJ, USA). Based on previous studies, [22] [23] [24] we estimate a sample with positive antigenemia result of 1 in 5 × 10 4 approximates to a viral load of between 500 and 1000 copies per ml if assessed by quantitative PCR. 
Assessment of KIR gene repertoire
Both cohorts were KIR genotyped using PCR-sequence-specific primer methodology as described previously. 41 Confirmatory genotyping was performed on 40 randomly selected DNA samples from the Cambridge cohort using a quantitative PCR to determine KIR copy number. 42 Full HLA class I genotyping of all subjects was carried out as described previously. 43 
Statistical analysis
All phenotype frequencies were initially calculated by direct counting from data produced by PCR-sequence-specific primer genotyping.
The relationship between the presence of individual KIR genes/ haplotypes and the rate of development of HCMV infection was presented using Kaplan-Meier curves with log-rank analysis (GraphPad Prism 5.02 for Windows, GraphPad Software, San Diego, CA, USA).
The influence of KIR gene repertoire on the development of clinically significant antigenemia thresholds was examined using a two-tailed Fisher's exact test using a 2 × 2 contingency table (GraphPad Prism 5.02). ORs with 95% CIs were also calculated (GraphPad Prism 5.02).
To evaluate the effect of individual KIR genes and haplotypes on peak HCMV antigenemia levels, maximum post-transplant antigenemia values were analyzed as a continuous variable using a two-tailed Mann-Whitney t-test (SPSS Statistics 19, IBM, Armonk, NY, USA).
The relationship between peak antigenemia level and the number of activating KIR genes was assessed using linear regression (GraphPad Prism 5.02), using maximum post-transplant antigenemia values as a continuous variable.
Multiple-testing correction was not performed in any of the statistical analyses.
